Acta Med. 1997, 40: 41-45

https://doi.org/10.14712/18059694.2020.42

Long-Term Results in Hairy Cell Leukemia Treated with 2-Chlorodeoxyadenosine

Ladislav Chrobáka, Pavel Žáka, Karel Podzimekb, Lenka Plíškovác, Jaroslava Foglováa, Vladimír Maisnara, Petr Dulíčeka, Karel Dědičd

aDepartment of Clinical Hematology, Charles University, Faculty of Medicine, Hradec Králové, Czech Republic
bIst Department of Medicine, Charles University, Faculty of Medicine, Hradec Králové, Czech Republic
cInstitute of Clinical Biochemistry and Diagnostics, Charles University, Faculty of Medicine, Hradec Králové, Czech Republic
dDepartment of Pathological Anatomy, Charles University, Faculty of Medicine, Hradec Králové, Czech Republic

Received May 1, 1997
Accepted June 1, 1997

References

1. Ambrosetti A, Semenzato G, Prior M et al. Serum levels of soluble interleukin-2-receptor in hairy cell leukemia: a reliable marker of neoplastic bulk. Br J Heamatol 1989; 73:181-6. <https://doi.org/10.1111/j.1365-2141.1989.tb00250.x>
2. Burke JS. The value of the bone marrow biopsy in the diagnosis of hairy cell leukemia. Am J Clin Pathol 1978; 70:876-84. <https://doi.org/10.1093/ajcp/70.6.876>
3. Chrobák L, Podzimek K, Kerekeš Z et al. Long-term results in hairy cell leukemia treated by splenectomy. Neoplasma 1993; 40:133-6.
4. Chrobák L, Podzimek K, Plíšková L. Serum soluble IL-2 receptor as reliable and non-invasive marker of disease activity in patients with hairy cell leukemia. Acta Medica (Hradec Králové) 1996; 39:3-6.
5. Chrobák L, Žák P, Podzimek K et al. Dyserythropoiesis and increased RdW in hairy cell leukemia. The chronic leukeamias, International Conference, Prague (Abstract) 1996:p. 72.
6. Ellison DJ, Sharpe RW, Robbins BA et al. Immunomorphologic analysis of bone marrow biopsies after treatment with 2-chlorodeoxyadenosine for hairy cell leukemia. Blood 1994; 84:4310-5. <https://doi.org/10.1182/blood.V84.12.4310.bloodjournal84124310>
7. Estey EH, Kurzrock R, Kantarjian H et al. Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine for hairy cell leukemia. Blood 1992; 79:882-7. <https://doi.org/10.1182/blood.V79.4.882.bloodjournal794882>
8. Filleul B, Delannoy A, Ferrant A et al. A single course of 2-chlorodeoxyadenosine does not eradicate leukemic cells in hairy cell leukemia patients in complete remission. Leukemia 1994; 7:1153-6.
9. Hakimian D, Tallman MS, Hogan DK et al. Prospective evaluation of internal adenopathy in a cohort of 43 patients with hairy cell leukemia. J Clin Oncol 1994; 12:268-72. <https://doi.org/10.1200/JCO.1994.12.2.268>
10. Hakimian D, Tallman MS, Kiley C et al. Detection of minimal residual disease by immunostaining of bone marrow biopsies after 2-chlorodeoxyadenosine for hairy cell leukemia. Blood 1993; 82:1798-1802. <https://doi.org/10.1182/blood.V82.6.1798.1798>
11. Hoffman M, Janson D, Aggarwal A et al. Long term results after treatment of hairy cell leukemia (HCL) with 2-chlorodeoxyadenosine (2-CdA). Blood 1995; 86(Suppl. 1):351a. <https://doi.org/10.1182/blood.V86.5.1794.bloodjournal8651794>
12. Juliusson G, Heldal D, Hippe E et al. Subcutaneous injections of 2-chlorodeoxyadenosine for symptomatic hairy cell leukemia. J Clin Oncol 1995; 13:989-95. <https://doi.org/10.1200/JCO.1995.13.4.989>
13. Lauria F, Benfenati D, Raspadori D et al. High complete remission rate in hairy cell leukemia treated with 2-chlorodeoxyadenosine. Leuk Lymph 1993; 11:399-404. <https://doi.org/10.3109/10428199309067932>
14. Mercieca J, Matutes E, Emmett E et al. 2-Chlorodeoxyadenosine in the treatment of hairy cell leukaemia: differences in response in patients with and without abdominal lymphadenopathy. Br J Haematol 1996; 93:409-11. <https://doi.org/10.1046/j.1365-2141.1996.5041045.x>
15. Nanba K, Soban EJ, Bowling MC et al. Splenic pseudosinuses and hepatic angiomatous lesions. Distinctive feature of hairy cell leukemia. Am J Clin Pathol 1977; 67: 415-26. <https://doi.org/10.1093/ajcp/67.5.415>
16. Piro LD, Carrera CJ, Carson DA et al. Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. N Engl J Med 1990; 322:1117-21. <https://doi.org/10.1056/NEJM199004193221605>
17. Richards JM, Mick R, Latta JM. Serum soluble interleukin - 2R receptor is associated with clinical and pathologic disease status in hairy cell leukemia. Blood 1990; 76:1941-5. <https://doi.org/10.1182/blood.V76.10.1941.1941>
18. Saven A, Piro LD. 2-chlorodeoxyadenosine in treatment of hairy cell leukemia and chronic lymphocytic leukemia. Leuk Lymph 1994; 11(Suppl. 2):109-14. <https://doi.org/10.3109/10428199309064270>
19. Tallman MS, Hakimian D, Rademaker AW et al. Relapse of hairy cell leukemia after 2-chlorodeoxyadenosine: long-term follow-up of the Northwestern university experience. Blood 1996; 88:1954-9. <https://doi.org/10.1182/blood.V88.6.1954.bloodjournal8861954>
20. Yam LT, Li CY, LAM KW. Tartarate resistant acid phosphotase isoenzyme in the reticulum cell of leukemia reticuloendotheliosis. N Engl J Med 1971; 284:357-60. <https://doi.org/10.1056/NEJM197102182840704>
21. Žák P, Chrobák L, Podzimek K et al. Neobvyklý průběh leukémie s vlasatými buňkami s výraznou abdominální lymphoadenopatií, leukemickými infiltráty oční rohovky a kožními změnami. Vnitr Lek 1996; 42:463-6.
22. Žák P, Chrobák L, Šimáková A et al. Zvětšení uzlin u leukémie s vlasatými buňkami a problematika výrazné abdominální lympfadenopatie. Vnitr Lek 1993; 39:896-901.
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal

Archive